Pages that link to "Q44846330"
Jump to navigation
Jump to search
The following pages link to Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study (Q44846330):
Displaying 50 items.
- Immunosuppressive agents for treating IgA nephropathy (Q24188035) (← links)
- Recent advances in the understanding and management of IgA nephropathy (Q26766126) (← links)
- Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy? (Q26852296) (← links)
- The Treatment of IgA Nephropathy (Q27005109) (← links)
- Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis (Q33805412) (← links)
- Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis (Q33919210) (← links)
- Current Therapy for IgA Nephropathy (Q34214875) (← links)
- Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy (Q34455482) (← links)
- Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy (Q34557198) (← links)
- The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis (Q34618530) (← links)
- Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review (Q34709848) (← links)
- Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset (Q35025425) (← links)
- Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children (Q35657080) (← links)
- Delta Neutrophil Index as a Marker for Differential Diagnosis between Acute Graft Pyelonephritis and Acute Graft Rejection (Q35746578) (← links)
- Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis (Q35926941) (← links)
- Mycophenolate mofetil in nonlupus glomerulonephropathy (Q36085861) (← links)
- Pharmacological management of renal fibrotic disease (Q36407348) (← links)
- Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects (Q36447934) (← links)
- The IgA nephropathy treatment dilemma (Q36461600) (← links)
- IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors (Q36577108) (← links)
- Current pharmacotherapy for the treatment of crescentic glomerulonephritis (Q36623061) (← links)
- Novel therapy for anti-glomerular basement membrane disease with IgA nephropathy: A case report (Q36824694) (← links)
- Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China (Q36949630) (← links)
- East Meets West: Harmony but Not Uniformity (Q37069894) (← links)
- Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? (Q37251705) (← links)
- An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases (Q37378976) (← links)
- Glomerular disease: why is there a dearth of high quality clinical trials? (Q37762438) (← links)
- An update on the pathogenesis and treatment of IgA nephropathy (Q37982634) (← links)
- Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease (Q38087925) (← links)
- Treatment of IgA nephropathy and Henoch-Schönlein nephritis (Q38094888) (← links)
- The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy (Q38409163) (← links)
- Primary glomerulonephritides (Q38752824) (← links)
- Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? (Q38860793) (← links)
- The clinical course of IgA nephropathy after kidney transplantation and its management (Q39139491) (← links)
- Inflammation in IgA nephropathy. (Q39178756) (← links)
- Is there a role for immunosuppression in immunoglobulin A nephropathy? (Q39229309) (← links)
- Posterior Scleritis: Analysis of Epidemiology, Clinical Factors, and Risk of Recurrence in a Cohort of 114 Patients. (Q40776679) (← links)
- Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy. (Q41471646) (← links)
- Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database (Q42691557) (← links)
- Long-term study of mycophenolate mofetil treatment in IgA nephropathy (Q43208703) (← links)
- IgA nephropathy in kidney allograft recipients-therapeutic perspective. (Q43814885) (← links)
- Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil (Q46410747) (← links)
- Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial (Q46442055) (← links)
- Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study (Q46788440) (← links)
- Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide (Q46846514) (← links)
- Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy (Q47773361) (← links)
- IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology. (Q49477908) (← links)
- Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment. (Q50740436) (← links)
- Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy (Q51083193) (← links)
- Tonsillectomy ameliorates histological damage of recurrent immunoglobulin A nephropathy after kidney transplantation (Q51214579) (← links)